Provided by Tiger Trade Technology Pte. Ltd.

CONSUN PHARMA

13.310
+0.1401.06%
Volume:1.37M
Turnover:18.30M
Market Cap:11.15B
PE:9.02
High:13.460
Open:13.240
Low:13.240
Close:13.170
52wk High:18.420
52wk Low:11.967
Shares:838.00M
HK Float Shares:838.00M
Volume Ratio:0.97
T/O Rate:0.16%
Dividend:0.80
Dividend Rate:6.02%
EPS(LYR):1.476
ROE:24.40%
ROA:12.58%
PB:2.00
PE(LYR):9.02
PS:2.62

Loading ...

Unveiling the Long-Term Potential of CONSUN PHARMA (01681): A Renal Care Leader Strengthening Its Growth Foundation Through Diversified Innovation

Stock News
·
Sep 18

Consun Pharma Repurchases 50,000 Shares; Treasury Stock Rises to 3.75 Million

Bulletin Express
·
Sep 17

CONSUN PHARMA Allocates HK$2.528 Million for Share Buyback on September 16

Stock News
·
Sep 16

CONSUN PHARMA Spends HKD 2.53 Million to Buy Back 193,000 Shares, Lifts Treasury Stock to 3.70 Million

Bulletin Express
·
Sep 16

Pharmaceutical Firm Completes Share Buyback Valued at Roughly 4 Million Hong Kong Dollars

Stock News
·
Sep 15

Consun Pharma Repurchases 406,000 Shares; Treasury Stock Rises to 3.21 Million

Bulletin Express
·
Sep 11

Consun Pharma Buys Back 305,000 Shares for HKD 4.00 Million, Boosting Treasury Stock to 2.80 Million

Bulletin Express
·
Sep 10

Consun Pharma Allocates HK$4 Million to Repurchase 305,000 Shares on September 10

Stock News
·
Sep 10

Consun Pharma Files HKEX Next-Day Disclosure Return After Share Repurchase for Treasury Shares

Reuters
·
Sep 10

Consun Pharmaceutical Group (SEHK:1681) Lifts Earnings And Dividend On A Valuation That Still Looks Cheap

Simply Wall St.
·
Sep 03

Consun Pharma Maintains Stable Share Capital in August 2026 Monthly Return

Bulletin Express
·
Sep 01

Consun Pharmaceutical Group And 2 Other Undiscovered Gems In Asia

Simply Wall St.
·
Aug 31

China's Gushengtang Holdings HY Revenue Rises on Offline Medical Institution Expansion

Reuters
·
Aug 28

HK Stock Market Highlights: Butong Group's Interim Profit Soars 98.28%, Plans AI Enhancements for Core Products

Stock News
·
Aug 27

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Consun Pharma FY26 H1 Profit Attributable to Shareholders Rises 19.5% to RMB 595.31 Million; Revenue Increases 13.8% to RMB 1.78 Billion

Reuters
·
Aug 26

Consun Pharmaceutical Declares Interim Dividend of HKD 0.38 Per Share

Reuters
·
Aug 26

Singapore's Thomson Medical Group FY Revenue Rises on Singapore Strength, Malaysia Oncology Contribution

Reuters
·
Aug 26

CONSUN PHARMA Sets October Date for Interim Dividend Payout

Stock News
·
Aug 26

CONSUN PHARMA Posts 19.5% Profit Growth in First-Half Results, Renal Product Line Up 18.1%

Stock News
·
Aug 26